Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 21. Click on ID to see further detail.
IDOV_2710 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration5 MOI | In-vitro result90% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2711 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration10 MOI | In-vitro result85% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2712 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration20 MOI | In-vitro result85% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2713 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration50 MOI | In-vitro result80% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2714 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration100 MOI | In-vitro result70% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2715 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration200 MOI | In-vitro result60% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2716 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (0.1 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration5 MOI | In-vitro result90% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2717 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (1 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration5 MOI | In-vitro result70% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2718 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (5 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration5 MOI | In-vitro result60% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2719 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (10 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration5 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2720 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration5 MOI | In-vitro result40% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2721 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration10 MOI | In-vitro result90% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2722 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration10 MOI | In-vitro result70% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2723 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration10 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2724 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration10 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2725 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration10 MOI | In-vitro result40% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2726 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration20 MOI | In-vitro result90% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2727 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration20 MOI | In-vitro result70% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2728 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration20 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2729 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration20 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |
IDOV_2730 | Virus nameAdenovirus | Virus strainSG600 | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1A, E1B promoter and E1ACR2 region | Virus aloneNo | Virus in combination with drug/radiationVirus strain in combination with vincristine (50 nm) | Immune gene insertion in viral genomeNo | Source of cell lineCentral south university,China | Origin of cell lineHuman retinoblastoma cell line | Cell lineHXO-RB44 | Concentration of cell lineNA | In-vitro toxicityNA | Assaycell proliferation kit analysis | In-vitro virus concentration20 MOI | In-vitro result40% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedS-phase arrest and induction of apotosis | Immunogenic effectDownregulation of Akt pathway | Clinical trialNA | PMID23109819 |